What We're Reading: Page 270
Industry reads hand-picked by our editors
Mar 22, 2018
Mar 21, 2018
-
Reuters
GlaxoSmithKline prescribes commercial reboot for pharma division
-
Regulatory Focus
FDA invites draft guidance on patient-focused drug development
-
The Wall Street Journal
A GOP right-to-try fumble
Mar 20, 2018
-
MIT Technology Review
AI can spot signs of Alzheimer’s before your family does
-
NPR
Shingles is nasty, and the new vaccine works well. Why do adults avoid shots?
-
The Boston Globe
Is Boston biotech in a bubble?
-
Bloomberg Gadfly
Beware biotech IPOs bearing Alzheimer's retreads
Mar 19, 2018
Mar 16, 2018
-
The Economist
Which firms profit most from America's health-care system
-
Bloomberg
Pfizer lifts CEO's pay 61% to $27.9 million with retention bonus
-
The Diplomat
China prepares for big pharma
Previous
